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CAMPTOCORMIA AND SHUFFLING GAIT DUE TO
A NOVEL MT-TV MUTATION: DIAGNOSTIC
PITFALLS
Camptocormia, the disabling flexion of the spine in
upright, but not supine position, has been reported
in a range of central nervous and neuromuscular con-
ditions and is associated with aging, too. In many cases,
e.g., Parkinson disease, further clinical symptoms will
clarify its association, if not pathophysiology. In others,
a tangle of signs and symptoms obscures the etiology.
Here, we present a new solution to this challenging and
complex clinical problem.
A 71-year-old Caucasian woman presented with
a 3-year history of unstable, short-stepping slow,
shuffling gait and complained of deteriorating hand-
writing. Her medical history included basalioma,
malignant melanoma, hypothyreosis, bilateral cata-
ract and hypoacusis, gastroesophageal reflux, predia-
betes, and thoracal and lumbal disc herniation.
While her mother and a brother suffer from type
II diabetes and a sister has a thyroid disorder, no
other recurrent, neuromuscular, or movement disor-
ders are known in the family. A brother died in
childhood of unclear causes, a further brother in
adulthood of a liver condition. Her son, daughter,
and 2 grandsons are well. Clinical examination re-
vealed slow horizontal saccades. Deep tendon re-
flexes were brisk, but for diminished ankle reflexes.
Babinski response was equivocal on the right. Mus-
cle tone and bulk appeared normal, but there was
weakness of proximal lower limb muscles and foot
extensors (MRC 4). Steps were short and their num-
ber for 180° turn increased. Positive Romberg test
and inability to tandem walking suggested sensory
ataxia, but sensory examination was otherwise nor-
mal. At follow-up, a slightly stooped posture pro-
gressed into camptocormia (figure, A) without signs
of dystonia or muscle rigidity. Mild weakness of
proximal arm muscles was found. Spinal MRI
showed cervical stenosis without signs of myelopa-
thy, but fatty replacement of paraspinal muscles.
Initial neurophysiologic examinations showed pro-
longed cortical latency after tibial nerve stimulation,
but transcranial stimulation gave normal total and
central motor conduction times, and EMG of the
vastus lateralis muscle was normal. Repeated neu-
rography revealed a mild sensorimotor polyneuro-
pathy. Levodopa treatment and CSF drainage under
the suspicion of Parkinson disease or normal pressure
hydrocephalus (NPH) due to enlarged lateral ventricles
in an otherwise unremarkable brain MRI and urge
incontinence were unsuccessful. DAT scan, EEG,
Holter ECG, blood pressure monitoring, orthostatic
test, and CSF analysis, including biomarkers for neuro-
degeneration (beta-amyloid, tau, and phospho-tau),
revealed no abnormalities. Mini-Mental State exami-
nation and Montreal Cognitive Assessment indicated
mild cognitive impairment. Maximum serum creatine
kinase was 236 U/L (,170 U/L). Genetic and anti-
body analysis ruled out facioscapulohumeral muscular
dystrophy types 1 and 2 as well as myasthenic syn-
dromes, respectively.
Biceps brachii muscle biopsy showed angular
atrophic fibers, a few degenerating fibers and
increased lipofuscin deposition. Modified Gomori
trichrome staining and oxidative enzyme reactions
revealed ragged red fibers and ;6% cytochrome
c oxidase (COX)-deficient fibers (figure, B). Occa-
sional ragged red fibers appeared COX positive. In
skeletal muscle tissue homogenate, activities of
mitochondrial respiratory chain complexes I and
IV normalized against citrate synthase activity were
mildly decreased to 0.07 (controls: 0.11 6 0.03
[n5 11]) and 1.38 (2.76 0.5 [n5 11]) U/g, respec-
tively, while quadruple OXPHOS immunofluores-
cence1 confirmed the presence of fibers lacking both
complex I (NDUFB8) and complex IV (COX-1)
expression, confirming a multiple respiratory chain
defect (figure, C). Mitochondrial DNA (mtDNA)
sequencing revealed a previously unreported hetero-
plasmic m.1660G.A MT-TV variant present at
highest levels in the muscle (35% mutation load), with
lower levels in urinary epithelial sediments (13%) and
blood (9%), consistent with the segregation pattern of
a pathogenic mtDNA mutation. Single-fiber segrega-
tion studies clearly confirmed pathogenicity, showing
a statistically significant higher m.1660G.A mutation
load in COX-deficient fibers (94.306 0.76 [n5 20])
than in COX-positive fibers (22.176 6.49 [n 5 18],
p , 0.0001, unpaired t test) (figure, D).
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Figure Clinical, histopathologic, and molecular genetic characterization of the m.1660G.A MT-TV mutation
(A) Camptocormia as the main clinical feature of the patient harboring the novel 1660G.A MT-TV mutation. (B) Serial
hematoxylin and eosin (B.a), modified Gomori trichrome staining (B.b), succinate dehydrogenase (SDH) (B.c), and cytochrome
c oxidase (COX)-SDHhistochemistry (B.d) showing ragged red fibers andCOX-deficient fibers (scale bar5 50mm). (C) Result of
the quadruple OXPHOS immunofluorescence analysis, confirming the presence of fibers lacking both complex I (NDUFB8) and
complex IV (COX-1) expressions. (D) Single muscle fiber mutation load segregation. The graph shows the mutation load
measured in individual COX-positive (closed dots) and COX-deficient fibers (open dots) laser microdissected from the
patient muscle biopsy. (E) Schematic representation of the cloverleaf structure of the mitochondrial (mt)-tRNA Val
molecule and the corresponding location of the pathogenic mutation (marked in red) and previous reported mt-tRNA
Val mutations (black). (F) Phylogenetic conservation of the appropriate regions of the mt-tRNA Val gene sequence for the
m.1660G.A mutation.
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Camptocormia has been reported in association
with myopathic and mitochondrial defects2–7 with
recent research suggesting limbmuscle biopsy as a rec-
ommended diagnostic procedure.7 Here, we demon-
strate a rare late-onset mitochondrial disorder due to
a novel pathogenic MT-TV mutation (figure, E and
F) mimicking much more common clinical condi-
tions like NPH, subcortical artherosclerotic encepha-
lopathy, or extrapyramidal movement disorders.
Particularly, the coexistence of a shuffling gait,
peripheral neuropathy, axial weakness, and bent spine
at an advanced age may masquerade a mitochondrial
pathophysiology and lead to erroneous diagnosis and
treatment. Our finding adds to the spectrum of dif-
ferential diagnostic considerations in gait and balance
disorders in the elderly and underlines the importance
of skeletal muscle biopsy as a major diagnostic tool in
these patients. Mitochondrial disorders frequently
lead to multisystemic disease and may manifest even
in late adulthood where symptomatic treatment op-
tions and tailored clinical advice are of utmost impor-
tance for affected patients.
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